Matches in Nanopublications for { ?s ?p ?o <http://rdf.disgenet.org/resource/nanopub/NP1249071.RADGGgt4_lYJGz9UYv2CA2lwX5DXXzvbZoHajFVsL3-hc130_provenance>. }
Showing items 1 to 9 of
9
with 100 items per page.
- source_evidence_literature type ECO_0000212 NP1249071.RADGGgt4_lYJGz9UYv2CA2lwX5DXXzvbZoHajFVsL3-hc130_provenance.
- source_evidence_literature label "DisGeNET evidence - LITERATURE" NP1249071.RADGGgt4_lYJGz9UYv2CA2lwX5DXXzvbZoHajFVsL3-hc130_provenance.
- source_evidence_literature comment "Gene-disease associations inferred from text-mining the literature." NP1249071.RADGGgt4_lYJGz9UYv2CA2lwX5DXXzvbZoHajFVsL3-hc130_provenance.
- NP1249071.RADGGgt4_lYJGz9UYv2CA2lwX5DXXzvbZoHajFVsL3-hc130_assertion description "[This retrospective study was aimed to investigate the efficacy of prophylactic agents in hepatocellular carcinoma (HCC) patients receiving TACE and compare the difference between lamivudine and entecavir.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." NP1249071.RADGGgt4_lYJGz9UYv2CA2lwX5DXXzvbZoHajFVsL3-hc130_provenance.
- NP1249071.RADGGgt4_lYJGz9UYv2CA2lwX5DXXzvbZoHajFVsL3-hc130_assertion evidence source_evidence_literature NP1249071.RADGGgt4_lYJGz9UYv2CA2lwX5DXXzvbZoHajFVsL3-hc130_provenance.
- NP1249071.RADGGgt4_lYJGz9UYv2CA2lwX5DXXzvbZoHajFVsL3-hc130_assertion SIO_000772 25520081 NP1249071.RADGGgt4_lYJGz9UYv2CA2lwX5DXXzvbZoHajFVsL3-hc130_provenance.
- NP1249071.RADGGgt4_lYJGz9UYv2CA2lwX5DXXzvbZoHajFVsL3-hc130_assertion wasDerivedFrom befree-2016 NP1249071.RADGGgt4_lYJGz9UYv2CA2lwX5DXXzvbZoHajFVsL3-hc130_provenance.
- NP1249071.RADGGgt4_lYJGz9UYv2CA2lwX5DXXzvbZoHajFVsL3-hc130_assertion wasGeneratedBy ECO_0000203 NP1249071.RADGGgt4_lYJGz9UYv2CA2lwX5DXXzvbZoHajFVsL3-hc130_provenance.
- befree-2016 importedOn "2016-02-19" NP1249071.RADGGgt4_lYJGz9UYv2CA2lwX5DXXzvbZoHajFVsL3-hc130_provenance.